An Information Portal to 110071 Biological Macromolecular Structures

[(1Z)-5-fluoro-2-methyl-1-{4-[methylsulfinyl]benzylidene}-1H-inden-3-yl]acetic acid
SUZ is found in 9 entries
  •   Chemical Component Summary   Hide
    Name [(1Z)-5-fluoro-2-methyl-1-{4-[methylsulfinyl]benzylidene}-1H-inden-3-yl]acetic acid
    Identifiers 2-[(3Z)-6-fluoro-2-methyl-3-[[4-[methylsulfinyl]phenyl]methylidene]inden-1-yl]ethanoic acid
    Synonyms SULINDAC
    Formula C20 H17 F O3 S
    Molecular Weight 356.41 g/mol
    Type non-polymer
    Isomeric SMILES
  •   Drug Info: DrugBank Hide
    DrugBank ID DB00605   (Different stereochemistry)
    Name Sulindac
    Groups approved
    Description Sulindac is a nonsteroidal anti-inflammatory agent (NSAIA) of the arylalkanoic acid class that is marketed in the U.S. by Merck as Clinoril. Like other NSAIAs, it may be used in the treatment of acute or chronic inflammatory conditions. Sulindac is a prodrug, derived from sulfinylindene, that is converted in vivo to an active sulfide compound by liver enzymes. The sulfide metabolite then undergoes enterohepatic circulation; it is excreted in the bile and then reabsorbed from the intestine. This is thought to help maintain constant blood levels with reduced gastrointestinal side effects. Some studies have shown sulindac to be relatively less irritating to the stomach than other NSAIA's except for drugs of the cyclooxygenase-2 (COX-2) inhibitor class. The exact mechanism of its NSAIA properties is unknown, but it is thought to act on enzymes COX-1 and COX-2, inhibiting prostaglandin synthesis.
    • (Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid
    • cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid
    • cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid
    • Clinoril
    • Sulindac
    • Sulindaco
    • Sulindacum
    Brand names Sulindac
    Affected organism Humans and other mammals
    Indication For acute or long-term use in the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute painful shoulder (acute subacromial bursitis/supraspinatus tendinitis), and acute gouty arthritis.
    Pharmacology Sulindac is a non-steroidal anti-inflammatory indene derivative, also possessing analgesic and antipyretic activities.
    Mechanism of action Sulindac's exact mechanism of action is unknown. Its antiinflammatory effects are believed to be due to inhibition of both COX-1 and COX-2 which leads to the inhibition of prostaglandin synthesis. Antipyretic effects may be due to action on the hypothalamus, resulting in an increased peripheral blood flow, vasodilation, and subsequent heat dissipation.
    Route of administration oral
    Categories Anti-Inflammatory Agents, Non-Steroidal
    ATC-Code M01AB02
    AHFS-Code 28:08.04.92
    CAS number 38194-50-2
    Name Sequence search Pharmacological action Actions
    Prostaglandin G/H synthase 1   Search  unknown inhibitor
    Prostaglandin G/H synthase 2   Search  yes inhibitor
    Aldose reductase   Search  unknown inhibitor
    Peroxisome proliferator-activated receptor delta   Search  unknown negative modulator
    Mitogen-activated protein kinase 3   Search  unknown inhibitor
Ligand Image